MITOMYCIN Side Effects

7010003-9 | C-reactive Protein Increased, Off Label Use, Temporal Arteritis
on Sep 03, 2010 Female patient from UNITED STATES , 71 years of age, was diagnosed with trabeculectomy and was treated with Mitomycin (View Usage). Patient experienced the following unwanted or unexpected effects: c-reactive protein increased, off label use, temporal arteritis. Mitomycin dosage: .

7009994-1 | Blood Alkaline Phosphatase Increased, Catheter Site Haemorrhage, Haemoglobin Decreased, Haemolysis, Hyperglycaemia, Hypertension, Jaundice, Off Label Use, Thrombotic Thrombocytopenic Purpura
Patient was taking Mitomycin (View Usage). Patient had the following side effects: blood alkaline phosphatase increased, catheter site haemorrhage, haemoglobin decreased, haemolysis, hyperglycaemia, hypertension, jaundice (What is jaundice?), off label use, thrombotic thrombocytopenic purpura on Sep 02, 2010 from UNITED STATES Additional patient health information: Female patient , 71 years of age, was diagnosed with therapeutic embolisation and. Mitomycin dosage: 10.00-mg- / Intrahepatic. During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ), DAUNORUBICIN HCL (View Daunorubicin Hcl Review and Daunorubicin Hcl Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ), ETHIODOL(ETHIODOL) (View Ethiodol(ethiodol) Review and Ethiodol(ethiodol) Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ).

7008790-9 | Intraocular Pressure Increased, Iris Adhesions, Off Label Use, Procedural Site Reaction, Scleral Thinning, Staphyloma, Uveal Prolapse
Adverse event was reported on Sep 03, 2010 by a Male patient taking Mitomycin (View Usage) (Dosage: ) was diagnosed with trabeculectomy and. Location: CANADA , 42 years of age, After Mitomycin was administered, patient had the following side effects: intraocular pressure increased, iris adhesions, off label use, procedural site reaction, scleral thinning, staphyloma, uveal prolapse.

7008789-2 | Iridocyclitis, No Therapeutic Response, Off Label Use
on Sep 03, 2010 Female patient from CANADA , 68 years of age, was diagnosed with trabeculectomy and was treated with Mitomycin (View Usage). Patient experienced the following unwanted or unexpected effects: iridocyclitis, no therapeutic response, off label use. Mitomycin dosage: .


7008788-0 | Blebitis, Iridocyclitis, Off Label Use
on Sep 03, 2010 Female patient from CANADA , 53 years of age, was diagnosed with trabeculectomy and was treated with Mitomycin (View Usage). Patient had the following side effects: blebitis, iridocyclitis, off label use. Mitomycin dosage: .

7008787-9 | Blebitis, Disease Recurrence, Iridocyclitis, Off Label Use
Patient was taking Mitomycin (View Usage). After Mitomycin was administered, patient had the following side effects: blebitis, disease recurrence, iridocyclitis, off label use on Sep 03, 2010 from CANADA Additional patient health information: Male patient , 64 years of age, was diagnosed with trabeculectomy and. Mitomycin dosage: .

7008786-7 | Blebitis, Iridocyclitis, Iritis, Off Label Use
Adverse event was reported on Sep 03, 2010 by a Male patient taking Mitomycin (View Usage) (Dosage: ) was diagnosed with trabeculectomy and. Location: CANADA , 37 years of age, Patient experienced the following unwanted or unexpected effects: blebitis, iridocyclitis, iritis, off label use.

7008785-5 | Anterior Chamber Inflammation, Endophthalmitis, Eye Infection Staphylococcal, Hypopyon, Keratitis Fungal, Off Label Use, Vitritis
on Sep 03, 2010 Female patient from GREECE , 46 years of age, was diagnosed with pterygium operation and was treated with Mitomycin (View Usage). Patient had the following side effects: anterior chamber inflammation, endophthalmitis, eye infection staphylococcal, hypopyon, keratitis fungal, off label use, vitritis. Mitomycin dosage: Topical. Patient was hospitalized.

7008703-X | Acute Respiratory Distress Syndrome, Diffuse Alveolar Damage, Interstitial Lung Disease, Off Label Use, Respiratory Failure
on Sep 02, 2010 Male patient from JAPAN , 84 years of age, was diagnosed with bladder cancer (What is bladder cancer?) and was treated with Mitomycin (View Usage). After Mitomycin was administered, patient had the following side effects: acute respiratory distress syndrome, diffuse alveolar damage, interstitial lung disease, off label use, respiratory failure. Mitomycin dosage: 20.00-mg- / Intravesical.

7008702-8 | Bladder Necrosis, Bladder Perforation, Off Label Use
Patient was taking Mitomycin (View Usage). Patient experienced the following unwanted or unexpected effects: bladder necrosis, bladder perforation, off label use on Sep 02, 2010 from TURKEY Additional patient health information: Male patient , 76 years of age, was diagnosed with bladder cancer (What is bladder cancer?) and. Mitomycin dosage: 40.00-mg- / Intravesical.

7007808-7 | Interstitial Lung Disease
Adverse event was reported on Sep 16, 2010 by a Male patient taking Mitomycin (View Usage) (Dosage: ) was diagnosed with bladder cancer (What is bladder cancer?) and. Location: JAPAN , 84 years of age, Patient had the following side effects: interstitial lung disease. Patient was hospitalized.

6969094-3 | Interstitial Lung Disease
on Sep 02, 2010 Male patient from JAPAN , 71 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Mitomycin (View Usage). After Mitomycin was administered, patient had the following side effects: interstitial lung disease. Mitomycin dosage: . During the same period patient was treated with CETUXIMAB (View Cetuximab Review and Cetuximab Label ), OXALIPLATIN (View Oxaliplatin Review and Oxaliplatin Label ), IRINOTECAN HCL (View Irinotecan Hcl Review and Irinotecan Hcl Label ). Patient was hospitalized.

6960861-9 | Colon Cancer, Discomfort, Disease Progression, Interstitial Lung Disease, Intestinal Obstruction, Metastases To Peritoneum, Obstruction Gastric, Off Label Use, Pain
on Aug 18, 2010 Female patient from UNITED STATES , 48 years of age, was diagnosed with adenocarcinoma and was treated with Mitomycin (View Usage). Patient experienced the following unwanted or unexpected effects: colon cancer, discomfort, disease progression, interstitial lung disease, intestinal obstruction, metastases to peritoneum, obstruction gastric, off label use, pain (What is pain?). Mitomycin dosage: Intrapleural. During the same period patient was treated with DOXOROBUCIN(DOXORUBICIN) (Intrapleural) (View Doxorobucin(doxorubicin) Review and Doxorobucin(doxorubicin) Label ), FLUOROURACIL (Intrapleural) (View Fluorouracil Review and Fluorouracil Label ), LEUCOVORIN(LEUCOVORIN) (View Leucovorin(leucovorin) Review and Leucovorin(leucovorin) Label ).

6959514-2 | Abdominal Pain, Bladder Necrosis, Dysuria
Patient was taking Mitomycin (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), bladder necrosis, dysuria on Aug 23, 2010 from JAPAN Additional patient health information: Male patient , 51 years of age, was diagnosed with urinary bladder polyp and. Mitomycin dosage: Route=ib; Injection. Patient was hospitalized and became disabled.

6933112-9 | Bronchopneumonia, Renal Impairment, Residual Urine Volume Increased, Urinary Tract Infection Staphylococcal
Adverse event was reported on Aug 12, 2010 by a Male patient taking Mitomycin (View Usage) (Dosage: Formulation:inj) was diagnosed with bladder transitional cell carcinoma and. Location: JAPAN , 80 years of age, After Mitomycin was administered, patient had the following side effects: bronchopneumonia, renal impairment, residual urine volume increased, urinary tract infection staphylococcal.

6923153-X | Bronchoalveolar Lavage Abnormal, Interstitial Lung Disease, Off Label Use, Pulmonary Hypertension, Respiratory Failure, Serratia Test Positive, Staphylococcus Test Positive
on Jul 26, 2010 Female patient from UNITED STATES , 71 years of age, was diagnosed with pancreatic carcinoma and was treated with Mitomycin (View Usage). Patient experienced the following unwanted or unexpected effects: bronchoalveolar lavage abnormal, interstitial lung disease, off label use, pulmonary hypertension (What is pulmonary hypertension?), respiratory failure, serratia test positive, staphylococcus test positive. Mitomycin dosage: 7.00-mg/m2. During the same period patient was treated with OXALIPLATIN (View Oxaliplatin Review and Oxaliplatin Label ), DOCETAXEL (View Docetaxel Review and Docetaxel Label ), CAPECITABINE (View Capecitabine Review and Capecitabine Label ), GEMCITABINE (View Gemcitabine Review and Gemcitabine Label ), IRINOTECAN HCL (View Irinotecan Hcl Review and Irinotecan Hcl Label ), CETUXIMAB (CETUXIMAB) (View Cetuximab (cetuximab) Review and Cetuximab (cetuximab) Label ). Patient was hospitalized.

6922719-0 | Eczema, Rash
on Aug 10, 2010 Male patient from JAPAN , 80 years of age, weighting 163.1 lb, was diagnosed with bladder papilloma and was treated with Mitomycin (View Usage). Patient had the following side effects: eczema (What is eczema?), rash (What is rash?). Mitomycin dosage: Inj.

6921785-6 | Corneal Epithelium Defect
Patient was taking Mitomycin (View Usage). After Mitomycin was administered, patient had the following side effects: corneal epithelium defect on Aug 11, 2010 from JAPAN Additional patient health information: Female patient , 81 years of age, was diagnosed with trabeculectomy and. Mitomycin dosage: Injection. Patient was hospitalized.

6920624-7 | Interstitial Lung Disease
Adverse event was reported on Aug 04, 2010 by a Male patient taking Mitomycin (View Usage) (Dosage: ) was diagnosed with prostate cancer (What is prostate cancer?) and. Location: JAPAN , 71 years of age, Patient experienced the following unwanted or unexpected effects: interstitial lung disease. During the same period patient was treated with CETUXIMAB (View Cetuximab Review and Cetuximab Label ), OXALIPLATIN (View Oxaliplatin Review and Oxaliplatin Label ), IRINOTECAN HCL (View Irinotecan Hcl Review and Irinotecan Hcl Label ). Patient was hospitalized.

6918975-5 | Corneal Epithelium Defect
on Jul 31, 2010 Female patient from JAPAN , 81 years of age, was diagnosed with papilloma and was treated with Mitomycin (View Usage). Patient had the following side effects: corneal epithelium defect. Mitomycin dosage: Route:io.

6914347-8 | Corneal Epithelium Defect
on Jul 31, 2010 Male patient from JAPAN , 69 years of age, was diagnosed with malignant neoplasm of conjunctiva and was treated with Mitomycin (View Usage). After Mitomycin was administered, patient had the following side effects: corneal epithelium defect. Mitomycin dosage: .

6914340-5 | Corneal Epithelium Defect
Patient was taking Mitomycin (View Usage). Patient experienced the following unwanted or unexpected effects: corneal epithelium defect on Jul 31, 2010 from JAPAN Additional patient health information: Female patient , 76 years of age, was diagnosed with malignant neoplasm of conjunctiva and. Mitomycin dosage: .

6905589-6 | Corneal Epithelium Defect, Visual Acuity Reduced
Adverse event was reported on Jul 29, 2010 by a Male patient taking Mitomycin (View Usage) (Dosage: Injection) was diagnosed with trabeculectomy and. Location: JAPAN , 76 years of age, Patient had the following side effects: corneal epithelium defect, visual acuity reduced. Patient was hospitalized.

6905577-X | Corneal Epithelium Defect
on Jul 29, 2010 Female patient from JAPAN , 81 years of age, was diagnosed with trabeculectomy and was treated with Mitomycin (View Usage). After Mitomycin was administered, patient had the following side effects: corneal epithelium defect. Mitomycin dosage: Injection.

6871849-0 | Interstitial Lung Disease
on Jul 15, 2010 Female patient from JAPAN , 65 years of age, was diagnosed with breast cancer recurrent and was treated with Mitomycin (View Usage). Patient experienced the following unwanted or unexpected effects: interstitial lung disease. Mitomycin dosage: Inj. During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ).

6866542-4 | Alopecia, Dysgeusia, Pruritus
Patient was taking Mitomycin (View Usage). Patient had the following side effects: alopecia, dysgeusia, pruritus on Apr 21, 2009 from UNITED STATES Additional patient health information: Female patient , 67 years of age, weighting 115.0 lb, was diagnosed with bladder cancer (What is bladder cancer?) and. Mitomycin dosage: .

6856865-7 | Corneal Epithelium Defect
Adverse event was reported on Jul 12, 2010 by a Male patient taking Mitomycin (View Usage) (Dosage: Injection) was diagnosed with trabeculectomy and. Location: JAPAN , 76 years of age, After Mitomycin was administered, patient had the following side effects: corneal epithelium defect.

6856861-X | Corneal Epithelium Defect
on Jul 12, 2010 Female patient from JAPAN , 81 years of age, was diagnosed with trabeculectomy and was treated with Mitomycin (View Usage). Patient experienced the following unwanted or unexpected effects: corneal epithelium defect. Mitomycin dosage: Injection.

6855214-8 | Autoimmune Hepatitis, Blood Immunoglobulin G Increased, Jaundice
on Jul 08, 2010 Female patient from UNITED KINGDOM , 75 years of age, was diagnosed with bladder cancer (What is bladder cancer?) and was treated with Mitomycin (View Usage). Patient had the following side effects: autoimmune hepatitis, blood immunoglobulin g increased, jaundice (What is jaundice?). Mitomycin dosage: Formulation:injection. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

6830227-0 | Interstitial Lung Disease
Patient was taking Mitomycin (View Usage). After Mitomycin was administered, patient had the following side effects: interstitial lung disease on Jul 01, 2010 from JAPAN Additional patient health information: Female patient , 65 years of age, was diagnosed with breast cancer recurrent and. Mitomycin dosage: Inj.

6822484-1 | Autoimmune Hepatitis, Blood Immunoglobulin G Increased, Jaundice
Adverse event was reported on Jun 29, 2010 by a Female patient taking Mitomycin (View Usage) (Dosage: Formulation:injection) was diagnosed with bladder cancer (What is bladder cancer?) and. Location: JAPAN , 75 years of age, Patient experienced the following unwanted or unexpected effects: autoimmune hepatitis, blood immunoglobulin g increased, jaundice (What is jaundice?). During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

6817870-X | Bone Marrow Failure, Decreased Appetite, Diarrhoea, Erythema Multiforme, Ileus, Urticaria
on Jun 28, 2010 Female patient from JAPAN , 54 years of age, was diagnosed with anal cancer (What is anal cancer?) and was treated with Mitomycin (View Usage). Patient had the following side effects: bone marrow failure, decreased appetite, diarrhoea, erythema multiforme, ileus, urticaria. Mitomycin dosage: Injection;04aug2008-04aug2008;14mg/body/day Bolus Iv(day 1). 10mg/m2 On Day1. During the same period patient was treated with FLUOROURACIL (5fu Inj 250 Kyowa Dr;04aug-04aug2008;1400mg/body/day,1000mg/m2 24hr Continuous Iv Inf(day1-4).) (View Fluorouracil Review and Fluorouracil Label ).

6791178-3 | Bone Marrow Failure, Decreased Appetite, Diarrhoea, Erythema Multiforme, Urticaria
on Jun 09, 2010 Female patient from JAPAN , 54 years of age, was diagnosed with anal cancer (What is anal cancer?) and was treated with Mitomycin (View Usage). After Mitomycin was administered, patient had the following side effects: bone marrow failure, decreased appetite, diarrhoea, erythema multiforme, urticaria. Mitomycin dosage: Injection;04aug2008-04aug2008;14mg/body/day Bolus Iv(day 1).. During the same period patient was treated with FLUOROURACIL (5fu Inj 250 Kyowa Dr;04aug-04aug2008;1400mg/body/day 24hr Continuous Iv Inf(day1-4).) (View Fluorouracil Review and Fluorouracil Label ).

6782515-4 | Bronchostenosis, Disease Recurrence, Off Label Use, Treatment Failure
Patient was taking Mitomycin (View Usage). Patient experienced the following unwanted or unexpected effects: bronchostenosis, disease recurrence, off label use, treatment failure on May 31, 2010 from SINGAPORE Additional patient health information: Female patient , 58 years of age, was diagnosed with bronchostenosis and. Mitomycin dosage: .

6781096-9 | Bone Marrow Failure, Decreased Appetite, Diarrhoea, Erythema Multiforme, Urticaria
Adverse event was reported on Jun 09, 2010 by a Female patient taking Mitomycin (View Usage) (Dosage: Injection;04aug2008-04aug2008;14mg/body/day Bolus Iv(day 1).) was diagnosed with anal cancer (What is anal cancer?) and. Location: JAPAN , 54 years of age, Patient had the following side effects: bone marrow failure, decreased appetite, diarrhoea, erythema multiforme, urticaria. During the same period patient was treated with FLUOROURACIL (5fu Inj 250 Kyowa Dr;04aug-04aug2008;1400mg/body/day 24hr Continuous Iv Inf(day1-4).) (View Fluorouracil Review and Fluorouracil Label ).

6772825-9 | Pruritus, Rash Papular
on Jun 07, 2010 Male patient from JAPAN , 67 years of age, was treated with Mitomycin (View Usage). After Mitomycin was administered, patient had the following side effects: pruritus, rash papular. Mitomycin dosage: .

6766825-2 | Corneal Disorder, Corneal Erosion, Corneal Oedema, Off Label Use
on May 24, 2010 Female patient from BELGIUM , 81 years of age, was diagnosed with trabeculectomy and was treated with Mitomycin (View Usage). Patient experienced the following unwanted or unexpected effects: corneal disorder, corneal erosion, corneal oedema, off label use. Mitomycin dosage: .

6766819-7 | Corneal Epithelium Defect, Corneal Oedema, Corneal Perforation, Off Label Use
Patient was taking Mitomycin (View Usage). Patient had the following side effects: corneal epithelium defect, corneal oedema, corneal perforation, off label use on May 24, 2010 from BELGIUM Additional patient health information: Male patient , 76 years of age, was diagnosed with trabeculectomy and. Mitomycin dosage: . Patient was hospitalized.

6712941-0 | Blebitis
Adverse event was reported on Apr 27, 2010 by a Male patient taking Mitomycin (View Usage) (Dosage: ) . Location: UNITED STATES , 71 years of age, After Mitomycin was administered, patient had the following side effects: blebitis.

6659946-6 | Pulmonary Arterial Hypertension
on Mar 23, 2010 Female patient from JAPAN , 66 years of age, was diagnosed with anal cancer (What is anal cancer?) and was treated with Mitomycin (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary arterial hypertension. Mitomycin dosage: Injection.

6656336-7 | Candidiasis, Stridor
on Mar 22, 2010 Female patient from UNITED KINGDOM , 67 years of age, was diagnosed with anal cancer (What is anal cancer?) and was treated with Mitomycin (View Usage). Patient had the following side effects: candidiasis, stridor. Mitomycin dosage: . During the same period patient was treated with FLUOROURACIL (1 Df=1gm/m2/day) (View Fluorouracil Review and Fluorouracil Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ).

6639832-8 | Iridocyclitis
Patient was taking Mitomycin (View Usage). After Mitomycin was administered, patient had the following side effects: iridocyclitis on Mar 08, 2010 from CANADA Additional patient health information: Male patient , 64 years of age, . Mitomycin dosage: .

6639817-1 | Iridocyclitis
Adverse event was reported on Mar 08, 2010 by a Male patient taking Mitomycin (View Usage) (Dosage: ) . Location: CANADA , 37 years of age, Patient experienced the following unwanted or unexpected effects: iridocyclitis.

6639815-8 | Iridocyclitis
on Mar 08, 2010 Female patient from CANADA , 68 years of age, was treated with Mitomycin (View Usage). Patient had the following side effects: iridocyclitis. Mitomycin dosage: .

6639785-2 | Iridocyclitis
on Mar 08, 2010 Male patient from CANADA , 53 years of age, was treated with Mitomycin (View Usage). After Mitomycin was administered, patient had the following side effects: iridocyclitis. Mitomycin dosage: .

6577987-4 | Anaemia, Decreased Appetite, Penis Carcinoma Recurrent
Patient was taking Mitomycin (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, decreased appetite, penis carcinoma recurrent on Jan 31, 2010 from JAPAN Additional patient health information: Male patient , 79 years of age, was diagnosed with penis carcinoma and. Mitomycin dosage: . During the same period patient was treated with BLEOMYCIN SULFATE (View Bleomycin Sulfate Review and Bleomycin Sulfate Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), CALCIUM FOLINATE (View Calcium Folinate Review and Calcium Folinate Label ).

6577981-3 | Decreased Appetite, Infection, Penis Carcinoma Recurrent, Peripheral Ischaemia, Ulcer
Adverse event was reported on Jan 31, 2010 by a Male patient taking Mitomycin (View Usage) (Dosage: ) was diagnosed with penis carcinoma and. Location: JAPAN , 48 years of age, Patient had the following side effects: decreased appetite, infection (What is infection?), penis carcinoma recurrent, peripheral ischaemia, ulcer (What is ulcer?). During the same period patient was treated with BLEOMYCIN SULFATE (View Bleomycin Sulfate Review and Bleomycin Sulfate Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), CALCIUM FOLINATE (View Calcium Folinate Review and Calcium Folinate Label ).

6577979-5 | Decreased Appetite, Febrile Neutropenia
on Jan 31, 2010 Male patient from JAPAN , 61 years of age, was diagnosed with penis carcinoma and was treated with Mitomycin (View Usage). After Mitomycin was administered, patient had the following side effects: decreased appetite, febrile neutropenia. Mitomycin dosage: . During the same period patient was treated with BLEOMYCIN SULFATE (View Bleomycin Sulfate Review and Bleomycin Sulfate Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), CALCIUM FOLINATE (View Calcium Folinate Review and Calcium Folinate Label ).

6577977-1 | Anaemia
on Jan 31, 2010 Female patient from JAPAN , 56 years of age, was diagnosed with penis carcinoma and was treated with Mitomycin (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia. Mitomycin dosage: . During the same period patient was treated with BLEOMYCIN SULFATE (View Bleomycin Sulfate Review and Bleomycin Sulfate Label ), CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), CALCIUM FOLINATE (View Calcium Folinate Review and Calcium Folinate Label ).

6567996-3 | Inflammation, Necrosis
Patient was taking Mitomycin (View Usage). Patient had the following side effects: inflammation, necrosis on Feb 02, 2010 from JAPAN Additional patient health information: Male patient , 76 years of age, was diagnosed with bladder cancer (What is bladder cancer?) and. Mitomycin dosage: Route: Intravenous Bolus(40mg).